Publication | Closed Access
Beta-2 microglobulin is a strong prognostic factor in patients with DLBCL receiving R-CHOP therapy
34
Citations
21
References
2015
Year
MedicineHematologyImmunologyPathologyR-chop TherapyStrong Prognostic FactorOncologyBeta-2 Microglobulin
| Year | Citations | |
|---|---|---|
Page 1
Page 1